Bone formation versus bone: Resorption in ankylosing spondylitis

Advances in Experimental Medicine and Biology

Volumn 649, Issue , 2009, Pages 114-121

  Schett, Georg ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 5; DICKKOPF 1 PROTEIN; GROWTH DIFFERENTIATION FACTOR; GROWTH DIFFERENTIATION FACTOR 5; NOGGIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PARATHYROID HORMONE; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; SOMATOMEDIN C; TRANSCRIPTION FACTOR RUNX2; WNT PROTEIN; WNT9A PROTEIN;

ANKYLOSING SPONDYLITIS; ARTICLE; BONE MALFORMATION; BONE MARROW DISEASE; BONE REMODELING; BONE STRESS; DISEASE COURSE; HUMAN; INTRACELLULAR SIGNALING; MICROMORPHOLOGY; MOLECULAR DYNAMICS; MUSCULOSKELETAL DEVELOPMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSSIFICATION; OSTEITIS; OSTEOBLAST; OSTEOLYSIS; OSTEOPHYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; BONE DEVELOPMENT; CYTOLOGY; HISTOLOGY; JOINT; MECHANICAL STRESS; OSTEOCYTE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ARTHRITIS, RHEUMATOID; BONE RESORPTION; HUMANS; JOINTS; OSTEOBLASTS; OSTEOCYTES; OSTEOGENESIS; SPONDYLITIS, ANKYLOSING; STRESS, MECHANICAL;

EID: 70349582721     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-0298-6_8     Document Type: Article

References (29)

1. Braun J, Landewé R, Hermann KG et al. Major reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with inflixirnab: Results of a multicenter, randomized, double-blind, placebo-controlled magnetic resonance imaging study. Arthritis Rheum 2006; 54:1646-52.
2. Davis J, van der Heijde D, Braun J et al. Recombinant human tumor necrosis factor receptor (Etanercept) for treating ankylosing spondylitis A randomized, controlled trial. Arthritis Rheum 2003; 48:3230-6; (Pubitemid 37409337)
3. van der Heijde D, Kivitz A, Schiff M et al. Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2006:54:2136-2.
4. Schett G, Landewé R, Desiree van der Heijde D. TNF blockers and structural remodeling in ankylosing spondylitis- what is reality and what is fiction? Ann Rheum Dis 2007; 66:709-11. (Pubitemid 46846687)
5. Schett G, Redlich K, Smolen JS. Inflammation-induced bone loss in the rheumatic diseases. In: Favus MJ, Ed. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 6th Edition. Washington D.C.: ASBMR, 2006; 6:310-313.
6. Gravallese EM, Harada Y, Wang JT et al. Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis. Am J Parhol 1998; 152:943-951. (Pubitemid 28173356)
7. Boers M, Kostense PJ, Verhoeven AC et al. Inflammation and damage in an individual joint predict further damage in that joint in patients with early rheumatoid arthritis. Arthritis Rheum 2001; 44:2242-6. (Pubitemid 32977491)
8. Scott DL, Pugner K, Kaarela K et al. The links between joint damage and disability in rheumatoid arthritis. Rheumatology (Oxford) 2000; 39:122-132. (Pubitemid 30139344)
9. Storm EE, Kingsley DM. Joint patterning defects caused by single and double mutations in members of the bone morphogenetic protein (BMP) family. Development 1996; 122:3969-79. (Pubitemid 27033891)
10. Hartmann C, Tabin CJ. Wnt-14 plays a pivotal role in inducing synovial joint formation in the developing appendicular skeleton. Cell 2001; 104:341-51. (Pubitemid 32206455)
11. Benjamin M, McGonagle D. The anatomical basis for disease localization in seronegative spondylar-throparhy at entheses and related sites. J Anat 2001; 199:503-526. (Pubitemid 33094612)
12. Ball J. Enthesopathy of rheumatoid and ankylosing spondylitis. Ann Rheum Dis 1971; 30(3):213-23.
13. Lories RJ, Derese I, Luyten FP. Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis. J Clin Invest 2005; 115:1571-9. (Pubitemid 40814665)
14. Appel H, Kuhne M, Spiekermann S et al. Immunohistologic analysis of zygapophyseal joints in patients with ankylosing spondylitis. Arthritis Rheum 2006; 54(9):2845-51. (Pubitemid 44497763)
15. Scharsruhl A, Vitters EL, van der Kraan PM et al. Reduction of osteophyte formation and synovial thickening by adenoviral overexpression of transforming growth factor beta/bone morphogenetic protein inhibitors during experimental osteoa rthr itis. Arthritis Rheum 2003; 48:3442-51. (Pubitemid 37531910)
16. Lories RJ, Derese I, de Bari C et al. Evidence for uncoupling of inflammation and joint remodeling in a mouse model of spondylarthritis. Arthritis Rheum 2007; 56(2):489-97 .
17. Lories RJ, Matthys P, de Vlam K et al. Ankylosing enthesitis, dactylitis and onychoperiostitis in male DBA/1 mice : a model of psoriatic arthritis . Ann Rheum Dis 2004; 63(5):595-8. (Pubitemid 38530208)
18. Miller JR. The Wnts. Genome Biol 2002; 3(1):3001.
19. Diarra D, Stolina M, Polzer K et al. Dickkopf-1 is a master regulator of joint remodeling. Nat Med 2007; 13:156-163.
20. Loties R, Peeters J, Bakker A et al. Deletion of Frzb affects articular cartilage and biomechanical poperties of the long bones. Arthritis Rheum 2007, in press.
21. McInnes I, Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Immunol 2007; 7:429-442. (Pubitemid 46834849)
22. Gough AK, Lilley J, Eyre S et al. Generalized bone loss in patients with early rheumatoid arthritis. Lancet 1994; 344:23-27. (Pubitemid 24199420)
23. Ralston SH, Urquhart GD, Brzeski M et al. Prevalence of vertebral compression fractures due to osteoporosis in ankylosing spondylitis. BMJ 1990; 300:563-565. (Pubitemid 20090269)
24. Schett G, Kiechl S, Weger S et al. High-sensitivity C-reakrive protein and risk of nontraumatic fractures in the bruneck study. Arch Int Med 2006; 166:2495-501. (Pubitemid 44913235)
25. Appel H, Loddenkernper C, Grozdanovic Z et al. Correlation of histopathological findings and magnetic resonance imaging in the spine of patients with ankylosing spondylitis. Arthritis Res Ther 2006; 22:R143.
26. Jimenez-Boj E, Nobauer-Huhmann I, Hanslik-Schnabel B et al. Bone erosions and bone marrow edema as defined by magnetic resonance imaging reflect true bone marrow inflammation in rheumatoid arthritis. Arthritis Rheum 2007; 56:1118-24. (Pubitemid 46608636)
27. Gortz B, Hayer S, Redlich K et al. Arthritis induces lymphocytic bone marrow inflammation and endosteal bone formation. J Bone Miner Res 2004 ; 19(6) :990-8. (Pubitemid 41103456)
28. Glass DA, Bialek P, Ahn JD et al. Canonical Wnt signaling in differentiated osteoblasrs controls osteoclast differentiation. Dev Cell 2005; 8:751-64. (Pubitemid 40585297)
29. van der Heijde DM. Landewé RB, Ory P et al. Two-year etanercept therapy does not inhibit radiographic progression in patients with ankylosing spondylitis. Ann Rheum Dis 2006; 65(Suppl II):81.